By staying at 0.25 milligrams initially, you gain time to adjust your eating patterns, test your tolerance to the medication, and establish whether this dose alone produces sufficient weight reduction for your goals
Regular kidney function monitoring (eGFR, uric acid) every 612 months during GLP-1 use supports early detection of adverse trends
Roche believes that combining an amylin analogue can help distribute the appetite-suppressing effect more gradually compared to GLP-1 monotherapy, while also reducing the intensity of gastrointestinal side effects such as nausea
If nausea arises, consider taking the drops at a different time of day
Gradual Dose Adjustments for Optimal Results As your semaglutide treatment progresses, we may recommend gradual dose adjustments to achieve the best possible outcomes
Discuss dosages with a physician before starting or changing a supplement regimen